30 years of historical data (1996–2025) · Healthcare · Medical - Distribution
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Cardinal Health, Inc. trades at 34.4x earnings, 12% below its 5-year average of 39.3x, sitting at the 89th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 55%. On a free-cash-flow basis, the stock trades at 28.2x P/FCF, 163% above the 5-year average of 10.7x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $52.2B | $40.7B | $24.3B | $24.8B | $14.6B | $16.8B | $15.3B | $14.2B | $15.4B | $24.9B | $25.7B |
| Enterprise Value | $57.7B | $46.1B | $24.8B | $25.9B | $15.7B | $20.1B | $19.3B | $19.7B | $22.6B | $28.5B | $28.9B |
| P/E Ratio → | 34.38 | 26.05 | 28.50 | 75.06 | — | 27.45 | — | 10.40 | 60.28 | 19.33 | 18.06 |
| P/S Ratio | 0.23 | 0.18 | 0.11 | 0.12 | 0.08 | 0.10 | 0.10 | 0.10 | 0.11 | 0.19 | 0.21 |
| P/B Ratio | — | — | — | — | — | 9.36 | 8.53 | 2.24 | 2.54 | 3.65 | 3.92 |
| P/FCF | 28.21 | 21.98 | 7.47 | 10.49 | 5.33 | 8.27 | 9.65 | 5.92 | 6.45 | 31.29 | 10.27 |
| P/OCF | 21.77 | 16.96 | 6.46 | 8.71 | 4.67 | 6.91 | 7.80 | 5.21 | 5.56 | 21.06 | 8.66 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Cardinal Health, Inc.'s enterprise value stands at 18.8x EBITDA, 62% below its 5-year average of 49.2x. The Healthcare sector median is 14.2x, placing the stock at a 32% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.21 | 0.11 | 0.13 | 0.09 | 0.12 | 0.13 | 0.14 | 0.17 | 0.22 | 0.24 |
| EV / EBITDA | 18.81 | 15.05 | 12.68 | 17.92 | 184.37 | 16.01 | — | 6.43 | 19.54 | 10.03 | 9.33 |
| EV / EBIT | 25.34 | 19.92 | 19.78 | 34.64 | — | 39.95 | — | 9.62 | 224.07 | 13.39 | 11.79 |
| EV / FCF | — | 24.93 | 7.62 | 10.95 | 5.73 | 9.90 | 12.17 | 8.22 | 9.49 | 35.70 | 11.54 |
Margins and return-on-capital ratios measuring operating efficiency
Cardinal Health, Inc. earns an operating margin of 1.0%. ROIC of 3378.7% represents excellent returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.7% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% |
| Operating Margin | 1.0% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% | -2.7% | 1.4% | 0.1% | 1.6% | 2.0% |
| Net Profit Margin | 0.7% | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% | 1.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -172.4% | 34.1% | -90.9% | 22.0% | 4.0% | 19.2% | 22.2% |
| ROA | 3.2% | 3.2% | 1.9% | 0.8% | -2.1% | 1.4% | -9.0% | 3.4% | 0.6% | 3.5% | 4.4% |
| ROIC | 3378.7% | 3378.7% | — | — | -16.6% | 6.5% | -34.9% | 12.3% | 0.8% | 15.8% | 21.8% |
| ROCE | 19.2% | 19.2% | 13.0% | 6.6% | -4.0% | 2.8% | -24.1% | 12.1% | 0.7% | 12.7% | 18.0% |
Solvency and debt-coverage ratios — lower is generally safer
Cardinal Health, Inc. carries a Debt/EBITDA ratio of 3.0x, which is moderately leveraged (5% below the sector average of 3.2x). Net debt stands at $5.5B ($9.3B total debt minus $3.9B cash). Interest coverage of 10.8x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | 3.74 | 3.78 | 1.27 | 1.49 | 1.52 | 0.84 |
| Debt / EBITDA | 3.05 | 3.05 | 2.87 | 3.58 | 68.29 | 5.35 | — | 2.62 | 7.78 | 3.66 | 1.79 |
| Net Debt / Equity | — | — | — | — | — | 1.84 | 2.23 | 0.87 | 1.20 | 0.51 | 0.48 |
| Net Debt / EBITDA | 1.78 | 1.78 | 0.24 | 0.76 | 12.80 | 2.64 | — | 1.80 | 6.26 | 1.24 | 1.03 |
| Debt / FCF | — | 2.96 | 0.15 | 0.47 | 0.40 | 1.63 | 2.53 | 2.30 | 3.04 | 4.41 | 1.27 |
| Interest Coverage | 10.77 | 10.77 | 24.55 | 8.89 | -4.33 | 2.79 | -14.85 | 6.96 | 0.31 | 10.57 | 13.79 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.94x is below 1.0, meaning current liabilities exceed current assets — though the company's $3.9B cash position helps mitigate short-term liquidity concerns. The quick ratio of 0.50x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.00x to 0.94x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | 0.94 | 0.98 | 1.00 | 1.08 | 1.12 | 1.10 | 1.07 | 1.07 | 1.34 | 1.11 |
| Quick Ratio | 0.50 | 0.50 | 0.56 | 0.52 | 0.57 | 0.60 | 0.54 | 0.54 | 0.53 | 0.80 | 0.58 |
| Cash Ratio | 0.10 | 0.10 | 0.14 | 0.12 | 0.15 | 0.12 | 0.12 | 0.10 | 0.08 | 0.32 | 0.12 |
| Asset Turnover | — | 4.19 | 5.03 | 4.73 | 4.13 | 3.65 | 3.75 | 3.55 | 3.42 | 3.24 | 3.56 |
| Inventory Turnover | 12.74 | 12.74 | 14.67 | 12.29 | 11.18 | 10.67 | 11.07 | 10.82 | 10.53 | 10.92 | 10.83 |
| Days Sales Outstanding | — | 21.72 | 19.45 | 19.78 | 21.26 | 20.45 | 19.72 | 21.19 | 20.81 | 22.60 | 22.24 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Cardinal Health, Inc. returns 2.4% to shareholders annually — split between a 0.9% dividend yield and 1.5% buyback yield. The payout ratio of 31.6% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.9% | 1.2% | 2.1% | 2.1% | 3.8% | 3.4% | 3.7% | 4.1% | 3.8% | 2.3% | 2.0% |
| Payout Ratio | 31.6% | 31.6% | 58.6% | 159.1% | — | 93.8% | — | 42.3% | 227.0% | 44.8% | 35.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.9% | 3.8% | 3.5% | 1.3% | — | 3.6% | — | 9.6% | 1.7% | 5.2% | 5.5% |
| FCF Yield | 3.5% | 4.6% | 13.4% | 9.5% | 18.8% | 12.1% | 10.4% | 16.9% | 15.5% | 3.2% | 9.7% |
| Buyback Yield | 1.5% | 1.9% | 3.1% | 8.1% | 6.9% | 1.2% | 2.3% | 4.2% | 3.6% | 2.4% | 2.5% |
| Total Shareholder Yield | 2.4% | 3.1% | 5.1% | 10.2% | 10.7% | 4.6% | 6.0% | 8.3% | 7.4% | 4.7% | 4.5% |
| Shares Outstanding | — | $242M | $247M | $262M | $279M | $294M | $293M | $301M | $315M | $320M | $330M |
Compare CAH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $52B | 34.4 | 18.8 | 28.2 | 3.7% | 1.0% | — | 3378.7% | 3.0 | |
| $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 | |
| $9B | 24.4 | 11.9 | 16.0 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 | |
| $171M | -0.2 | 1.7 | — | — | 1.0% | -2111.6% | 1.8% | 2.6 | |
| $5B | 54.7 | 7.0 | 6.7 | 39.0% | 17.4% | 5.0% | 7.4% | 4.2 | |
| $550B | 39.4 | 19.1 | 27.7 | 69.1% | 24.9% | 20.1% | 20.7% | 1.2 | |
| $143B | 18.5 | 10.3 | 15.8 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 | |
| $154B | 11.6 | 16.1 | 24.2 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 | |
| $52B | 24.7 | 14.0 | 19.5 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 | |
| $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| $84B | 13.2 | 8.6 | 10.9 | 41.5% | 15.8% | — | 19.9% | 3.2 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Deep dive into CAH consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CAH stock.
Cardinal Health, Inc.'s current P/E ratio is 34.4x. The historical average is 24.2x. This places it at the 89th percentile of its historical range.
Cardinal Health, Inc.'s current EV/EBITDA is 18.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.0x.
Based on historical data, Cardinal Health, Inc. is trading at a P/E of 34.4x. This is at the 89th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Cardinal Health, Inc.'s current dividend yield is 0.92% with a payout ratio of 31.6%.
Cardinal Health, Inc. has 3.7% gross margin and 1.0% operating margin.
Cardinal Health, Inc.'s Debt/EBITDA ratio is 3.0x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.